Food and Drug Administration officially authorizes the usage of a third dosage of the Pfizer–BioNTech COVID-19 vaccine
The Food and Drug Administration officially authorizes the usage of a third dosage of the Pfizer–BioNTech COVID-19 vaccine as a booster shot for individuals still considered vulnerable to COVID-19. Among those eligible are health care workers and senior citizens who have been fully inoculated with the vaccine for at least six months.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
The Food and Drug Administration officially authorizes the usage of a third dosage of the Pfizer–BioNTech COVID-19 vaccine as a booster shot for individuals still considered vulnerable to COVID-19. Among those eligible are health care workers and senior citizens who have been fully inoculated with the vaccine for at least six months.